These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8503612)
1. [Update on consensual proposals (1993 February). Role of cotrimoxazole in the primary prevention of toxoplasmosis in patients with HIV infection]. Leport C; Ambroise-Thomas P; Chêne G; Derouin F; Katlama C; Raffi F; Vildé JL Ann Med Interne (Paris); 1993; 144(1):56-7. PubMed ID: 8503612 [No Abstract] [Full Text] [Related]
2. [Consensual proposals for the treatment of toxoplasmosis in patients with human immunodeficiency virus infection]. Leport C; Ambroise-Thomas P; Chêne G; Katlama C; Raffi F; Vildé JL Ann Med Interne (Paris); 1993; 144(1):53-6. PubMed ID: 8503611 [No Abstract] [Full Text] [Related]
3. Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa? Samb B; Badiane M; Kony S; Larouzé B; Faye MA; Sow PS; Badiane S; Metro A; Costagliola D; Ndoye I; Delaporte E; Coll-Seck AM; Coulaud JP AIDS; 1998 Mar; 12(4):447. PubMed ID: 9520181 [No Abstract] [Full Text] [Related]
4. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012 [TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Ioannidis JP; Cappelleri JC; Skolnik PR; Lau J; Sacks HS Arch Intern Med; 1996 Jan; 156(2):177-88. PubMed ID: 8546551 [TBL] [Abstract][Full Text] [Related]
7. Study finds NAC fails to prevent Bactrim/Septra hypersensitivity. TreatmentUpdate; 1999 Feb; 11(1):4-5. PubMed ID: 11366023 [TBL] [Abstract][Full Text] [Related]
8. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus. Popa LG; Popa MI; Zaharia A; Ocneanu M Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456 [TBL] [Abstract][Full Text] [Related]
9. Cotrimoxazole prophylaxis for infants exposed to HIV infection. Graham SM Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259 [No Abstract] [Full Text] [Related]
10. [Prevention of toxoplasmosis in immunocompromised patients]. Morlat P; Leport C Ann Med Interne (Paris); 1997; 148(3):235-9. PubMed ID: 9255332 [TBL] [Abstract][Full Text] [Related]
11. [Primary prevention of toxoplasmosis in patients with HIV infection]. Peńa JM; Vázquez JJ Med Clin (Barc); 1994 Apr; 102(16):621-3. PubMed ID: 8208039 [No Abstract] [Full Text] [Related]
12. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases. Dworkin MS; Williamson J; Jones JL; Kaplan JE; Clin Infect Dis; 2001 Aug; 33(3):393-8. PubMed ID: 11438910 [TBL] [Abstract][Full Text] [Related]
13. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi. Zachariah R; Harries AD; Arendt V; Wennig R; Schneider S; Spielmann M; Panarotto E; Gomani P; Salaniponi FM Int J Tuberc Lung Dis; 2001 Sep; 5(9):843-6. PubMed ID: 11573896 [TBL] [Abstract][Full Text] [Related]
14. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763 [TBL] [Abstract][Full Text] [Related]
15. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC; Rimland D Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975 [TBL] [Abstract][Full Text] [Related]
16. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796 [TBL] [Abstract][Full Text] [Related]
17. Polymorphous hemangioendothelioma in a child with acquired immunodeficiency syndrome (AIDS). Paul SR; Hurford MT; Miettinen MM; Aronoff SC; Delvecchio M; Grewal H; Tuluc M Pediatr Blood Cancer; 2008 Mar; 50(3):663-5. PubMed ID: 16991137 [TBL] [Abstract][Full Text] [Related]
18. Infectious disease emergencies in persons with HIV/AIDS: an update. Lucey DR; Lucey CR J Ark Med Soc; 1990 Sep; 87(4):156-61. PubMed ID: 2146250 [No Abstract] [Full Text] [Related]
19. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi. Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111 [TBL] [Abstract][Full Text] [Related]
20. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS. Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150 [No Abstract] [Full Text] [Related] [Next] [New Search]